Wells Fargo & Company Igm Biosciences, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 4,987 shares of IGMS stock, worth $44,334. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,987

Previous 5,133 2.84%

Holding current value

$44,334

Previous $35,000 134.29%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$6.28 - $17.68 $916 - $2,581	-146 Reduced 2.84%	4,987 $82,000
Q2 2024 Aug 13, 2024	BUY	$6.51 - $11.47 $1,913 - $3,372	294 Added 6.08%	5,133 $35,000
Q1 2024 May 10, 2024	BUY	$8.68 - $17.36 $5,242 - $10,485	604 Added 14.26%	4,839 $46,000
Q4 2023 Feb 09, 2024	BUY	$3.94 - $8.79 $4,467 - $9,967	1,134 Added 36.57%	4,235 $35,000
Q3 2023 Nov 13, 2023	SELL	$6.66 - $10.64 $10,303 - $16,460	-1,547 Reduced 33.28%	3,101 $25,000
Q2 2023 Aug 15, 2023	BUY	$8.86 - $14.0 $22,406 - $35,406	2,529 Added 119.35%	4,648 $42,000
Q1 2023 May 12, 2023	BUY	$13.74 - $25.76 $27,397 - $51,365	1,994 Added 1595.2%	2,119 $29,000
Q4 2022 Feb 13, 2023	SELL	$15.45 - $26.02 $4,387 - $7,389	-284 Reduced 69.44%	125 $2,000
Q3 2022 Nov 14, 2022	SELL	$15.42 - $27.01 $185 - $324	-12 Reduced 2.85%	409 $9,000
Q2 2022 Aug 12, 2022	BUY	$13.27 - $25.5 $3,927 - $7,548	296 Added 236.8%	421 $7,000
Q1 2022 May 16, 2022	SELL	$13.42 - $29.73 $50,928 - $112,825	-3,795 Reduced 96.81%	125 $3,000
Q4 2021 Feb 14, 2022	SELL	$27.59 - $66.39 $115,353 - $277,576	-4,181 Reduced 51.61%	3,920 $115,000
Q3 2021 Nov 15, 2021	SELL	$65.76 - $90.65 $804,573 - $1.11 Million	-12,235 Reduced 60.16%	8,101 $533,000
Q2 2021 Aug 16, 2021	BUY	$57.98 - $96.6 $412,817 - $687,792	7,120 Added 53.87%	20,336 $1.69 Million
Q1 2021 May 13, 2021	SELL	$71.56 - $121.23 $599,672 - $1.02 Million	-8,380 Reduced 38.8%	13,216 $1.01 Million
Q4 2020 Feb 09, 2021	BUY	$47.41 - $115.03 $663,265 - $1.61 Million	13,990 Added 183.93%	21,596 $1.91 Million
Q3 2020 Nov 05, 2020	SELL	$43.0 - $84.01 $130,462 - $254,886	-3,034 Reduced 28.52%	7,606 $561,000
Q2 2020 Aug 13, 2020	SELL	$51.3 - $75.21 $282,303 - $413,880	-5,503 Reduced 34.09%	10,640 $776,000
Q1 2020 May 14, 2020	BUY	$31.51 - $73.75 $508,665 - $1.19 Million	16,143 New	16,143 $906,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $258M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Igm Biosciences, Inc. Transaction History